Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-24 | Mr. Hoberman is currently the Chief Operating Officer and Corporate Secretary of Stemline Therapeutics, Inc. where he was a key member of the founding team. He has extensive financial, accounting, investor relations, corporate governance and business development experience. |
| 2016-04-29 | He received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. |
| 2017-04-28 | Mr. Hoberman is currently the Chief Operating Officer and Corporate Secretary of Stemline Therapeutics, Inc. where he was a key member of the founding team. He has extensive financial, accounting, investor relations, corporate governance and business development experience. |
| 2018-04-30 | Mr. Hoberman is currently the Chief Operating Officer and Corporate Secretary of Stemline Therapeutics, Inc. He received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. |
| 2019-04-30 | He received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. |
| 2020-04-29 | He received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. |
| 2021-04-30 | He received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. |
| 2022-04-29 | He received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. Based on Mr. Hoberman’s financial and pharmaceutical industry experience and in-depth understanding of our business, as well as his extensive management experience, the Board of Directors believes that Mr. Hoberman has the appropriate set of skills to serve as a member of the Board. |
| 2023-05-01 | Mr. Hoberman received a B.S.B.A. in Finance from Boston University and completed post-baccalaureate studies at Columbia University. He has extensive financial, accounting, investor relations, corporate governance and business development experience. |
| 2024-04-29 | Mr. Hoberman is currently the Chief Operating Officer and Corporate Secretary of Stemline Therapeutics, Inc. with extensive financial, accounting, investor relations, corporate governance and business development experience. |
Data sourced from SEC filings. Last updated: 2025-10-11